Calretinin, CD34, and αsmooth muscle actin in the identification of peritoneal invasive implants of serous borderline tumors of the ovary

Eung Seok Lee, Anthony S Y Leong, Young Sik Kim, Ju-Han Lee, Insun Kim, Hwan Ahn Geung, Sun Kim Hye, Kyeong Chun Yi

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The correct identification of invasive implants in the peritoneum in serous borderline tumors (SBTs) of the ovary is an important determinant of diagnosis, treatment, and prognosis. Although the histologic criteria to distinguish noninvasive from invasive implants have been defined, the distinction can still be difficult. We examined the presence and distribution of mesothelial cells, stromal fibrocytes, and myofibroblasts in invasive and noninvasive peritoneal implants in 100 noninvasive, 100 invasive, and 100 metastatic nests/foci from 20 cases of SBTs with peritoneal implants, 10 serous carcinomas with peritoneal metastasis, and 10 cases of endosalpingiosis by immunostaining for calretinin, CD34, and α-SMA. All 100 invasive nests from seven SBTs and all 100 metastatic nests from the cases of serous carcinoma showed loss of calretinin + mesothelial cells and stromal CD34 fibrocytes around the nests. In contrast, 72/100 noninvasive nests displayed the presence of mesothelial cells around the nests and 68 displayed preservation of surrounding stromal fibrocytes. α-smooth muscle actin positive myofibroblasts were present as a stromal response in 100/100 metastatic nests, 100/100 invasive nests and 54/100 noninvasive nests. The loss of mesothelial cells and stromal fibrocytes surrounding invasive nests together with a proliferation of myofibroblasts as demonstrated by immunostaining proved to be a sensitive and specific tool to separate invasive from noninvasive implants and represents an important adjunct to morphologic diagnosis. Combined sensitivity and specificity of the three antibodies was 100 and 81%, respectively. These methods, however, may not be helpful for small biopsies of noninvasive desmoplastic implants. The distribution of these cells provides some insights into the histogenesis of invasive and noninvasive implants in SBTs.

Original languageEnglish
Pages (from-to)364-372
Number of pages9
JournalModern Pathology
Volume19
Issue number3
DOIs
Publication statusPublished - 2006 Mar 1

Fingerprint

Calbindin 2
Smooth Muscle
Myofibroblasts
Actins
Ovary
Stromal Cells
Neoplasms
Carcinoma
Peritoneum
Neoplasm Metastasis
Biopsy
Sensitivity and Specificity
Antibodies

Keywords

  • Immunohistochemistry
  • Invasive implants
  • Ovarian serous borderline tumors

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Calretinin, CD34, and αsmooth muscle actin in the identification of peritoneal invasive implants of serous borderline tumors of the ovary. / Lee, Eung Seok; Leong, Anthony S Y; Kim, Young Sik; Lee, Ju-Han; Kim, Insun; Geung, Hwan Ahn; Hye, Sun Kim; Yi, Kyeong Chun.

In: Modern Pathology, Vol. 19, No. 3, 01.03.2006, p. 364-372.

Research output: Contribution to journalArticle

@article{76a9e80d8362425ab2c6f5f8e292587d,
title = "Calretinin, CD34, and αsmooth muscle actin in the identification of peritoneal invasive implants of serous borderline tumors of the ovary",
abstract = "The correct identification of invasive implants in the peritoneum in serous borderline tumors (SBTs) of the ovary is an important determinant of diagnosis, treatment, and prognosis. Although the histologic criteria to distinguish noninvasive from invasive implants have been defined, the distinction can still be difficult. We examined the presence and distribution of mesothelial cells, stromal fibrocytes, and myofibroblasts in invasive and noninvasive peritoneal implants in 100 noninvasive, 100 invasive, and 100 metastatic nests/foci from 20 cases of SBTs with peritoneal implants, 10 serous carcinomas with peritoneal metastasis, and 10 cases of endosalpingiosis by immunostaining for calretinin, CD34, and α-SMA. All 100 invasive nests from seven SBTs and all 100 metastatic nests from the cases of serous carcinoma showed loss of calretinin + mesothelial cells and stromal CD34 fibrocytes around the nests. In contrast, 72/100 noninvasive nests displayed the presence of mesothelial cells around the nests and 68 displayed preservation of surrounding stromal fibrocytes. α-smooth muscle actin positive myofibroblasts were present as a stromal response in 100/100 metastatic nests, 100/100 invasive nests and 54/100 noninvasive nests. The loss of mesothelial cells and stromal fibrocytes surrounding invasive nests together with a proliferation of myofibroblasts as demonstrated by immunostaining proved to be a sensitive and specific tool to separate invasive from noninvasive implants and represents an important adjunct to morphologic diagnosis. Combined sensitivity and specificity of the three antibodies was 100 and 81{\%}, respectively. These methods, however, may not be helpful for small biopsies of noninvasive desmoplastic implants. The distribution of these cells provides some insights into the histogenesis of invasive and noninvasive implants in SBTs.",
keywords = "Immunohistochemistry, Invasive implants, Ovarian serous borderline tumors",
author = "Lee, {Eung Seok} and Leong, {Anthony S Y} and Kim, {Young Sik} and Ju-Han Lee and Insun Kim and Geung, {Hwan Ahn} and Hye, {Sun Kim} and Yi, {Kyeong Chun}",
year = "2006",
month = "3",
day = "1",
doi = "10.1038/modpathol.3800539",
language = "English",
volume = "19",
pages = "364--372",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Calretinin, CD34, and αsmooth muscle actin in the identification of peritoneal invasive implants of serous borderline tumors of the ovary

AU - Lee, Eung Seok

AU - Leong, Anthony S Y

AU - Kim, Young Sik

AU - Lee, Ju-Han

AU - Kim, Insun

AU - Geung, Hwan Ahn

AU - Hye, Sun Kim

AU - Yi, Kyeong Chun

PY - 2006/3/1

Y1 - 2006/3/1

N2 - The correct identification of invasive implants in the peritoneum in serous borderline tumors (SBTs) of the ovary is an important determinant of diagnosis, treatment, and prognosis. Although the histologic criteria to distinguish noninvasive from invasive implants have been defined, the distinction can still be difficult. We examined the presence and distribution of mesothelial cells, stromal fibrocytes, and myofibroblasts in invasive and noninvasive peritoneal implants in 100 noninvasive, 100 invasive, and 100 metastatic nests/foci from 20 cases of SBTs with peritoneal implants, 10 serous carcinomas with peritoneal metastasis, and 10 cases of endosalpingiosis by immunostaining for calretinin, CD34, and α-SMA. All 100 invasive nests from seven SBTs and all 100 metastatic nests from the cases of serous carcinoma showed loss of calretinin + mesothelial cells and stromal CD34 fibrocytes around the nests. In contrast, 72/100 noninvasive nests displayed the presence of mesothelial cells around the nests and 68 displayed preservation of surrounding stromal fibrocytes. α-smooth muscle actin positive myofibroblasts were present as a stromal response in 100/100 metastatic nests, 100/100 invasive nests and 54/100 noninvasive nests. The loss of mesothelial cells and stromal fibrocytes surrounding invasive nests together with a proliferation of myofibroblasts as demonstrated by immunostaining proved to be a sensitive and specific tool to separate invasive from noninvasive implants and represents an important adjunct to morphologic diagnosis. Combined sensitivity and specificity of the three antibodies was 100 and 81%, respectively. These methods, however, may not be helpful for small biopsies of noninvasive desmoplastic implants. The distribution of these cells provides some insights into the histogenesis of invasive and noninvasive implants in SBTs.

AB - The correct identification of invasive implants in the peritoneum in serous borderline tumors (SBTs) of the ovary is an important determinant of diagnosis, treatment, and prognosis. Although the histologic criteria to distinguish noninvasive from invasive implants have been defined, the distinction can still be difficult. We examined the presence and distribution of mesothelial cells, stromal fibrocytes, and myofibroblasts in invasive and noninvasive peritoneal implants in 100 noninvasive, 100 invasive, and 100 metastatic nests/foci from 20 cases of SBTs with peritoneal implants, 10 serous carcinomas with peritoneal metastasis, and 10 cases of endosalpingiosis by immunostaining for calretinin, CD34, and α-SMA. All 100 invasive nests from seven SBTs and all 100 metastatic nests from the cases of serous carcinoma showed loss of calretinin + mesothelial cells and stromal CD34 fibrocytes around the nests. In contrast, 72/100 noninvasive nests displayed the presence of mesothelial cells around the nests and 68 displayed preservation of surrounding stromal fibrocytes. α-smooth muscle actin positive myofibroblasts were present as a stromal response in 100/100 metastatic nests, 100/100 invasive nests and 54/100 noninvasive nests. The loss of mesothelial cells and stromal fibrocytes surrounding invasive nests together with a proliferation of myofibroblasts as demonstrated by immunostaining proved to be a sensitive and specific tool to separate invasive from noninvasive implants and represents an important adjunct to morphologic diagnosis. Combined sensitivity and specificity of the three antibodies was 100 and 81%, respectively. These methods, however, may not be helpful for small biopsies of noninvasive desmoplastic implants. The distribution of these cells provides some insights into the histogenesis of invasive and noninvasive implants in SBTs.

KW - Immunohistochemistry

KW - Invasive implants

KW - Ovarian serous borderline tumors

UR - http://www.scopus.com/inward/record.url?scp=33244473680&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33244473680&partnerID=8YFLogxK

U2 - 10.1038/modpathol.3800539

DO - 10.1038/modpathol.3800539

M3 - Article

VL - 19

SP - 364

EP - 372

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 3

ER -